Jose Manuel Otero

Companies

• Lexeo Therapeutics, Inc.Chief operating officer Feb 6, 2026 to now¹
• Lexeo Therapeutics, Inc.Chief Technical Officer May 22, 2024 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LTLexeo Therapeutics, Inc. LXEO138,288 shares³$373.4K at $2.70Sep 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 14, 2026Granted 2,110 shares at $2.64 of Lexeo Therapeutics, Inc.³
• Aug 18, 2026Sold 1,304 shares at $4.96 of Lexeo Therapeutics, Inc.⁴
• Jul 1, 2026Sold 4,666 shares at $4.48 of Lexeo Therapeutics, Inc.⁵
• Jun 29, 2026Granted 12,060 shares of Lexeo Therapeutics, Inc.⁵
• May 18, 2026Sold 1,302 shares at $5.07 of Lexeo Therapeutics, Inc.⁶
• Mar 13, 2026Granted 5,930 shares at $2.64 of Lexeo Therapeutics, Inc.⁷
• Feb 18, 2026Sold 3,016 shares at $6.40 of Lexeo Therapeutics, Inc.⁸
• Feb 4, 2026Granted 65,000 shares of Lexeo Therapeutics, Inc.⁹
• Nov 18, 2025Sold 721 shares at $9.27 of Lexeo Therapeutics, Inc.¹⁰
• Oct 17, 2025Sold 24 shares at $9.56 of Lexeo Therapeutics, Inc.¹¹
• Oct 17, 2025Sold 2,091 shares at $8.94 of Lexeo Therapeutics, Inc.¹¹
• Oct 15, 2025Granted 5,940 shares of Lexeo Therapeutics, Inc.¹¹
• Aug 18, 2025Sold 2,848 shares at $4.67 of Lexeo Therapeutics, Inc.¹²
• Aug 18, 2025Sold 721 shares at $9.27 of Lexeo Therapeutics, Inc.¹³
• Mar 14, 2025Granted 5,720 shares at $2.61 of Lexeo Therapeutics, Inc.¹⁴
• Jan 7, 2025Granted 26,250 shares of Lexeo Therapeutics, Inc.¹⁵
• Jun 12, 2024Granted 31,250 shares of Lexeo Therapeutics, Inc.¹⁶